References
- Hall H., Högberg T., Halldin C., Köhler C., Ström P., Ross S., Larsson S. A., Farde L. NCQ 298, a new selective iodinated salicylamide ligand for labelling of dopamine D2 receptors. Psychopharmacology 1991; 103: 6–18
- Malmberg Å.H., Jackson D. M., Hacksell U., Johansson A. M., Eriksson A-M., Mohell N. A. Pharmacological characterization of human dopamine D2A, D2B and D3 receptors. Soc. Neurosci. Abstr. 1992; 18: 1171
- Högberg T., Ström P., Hall H., Köhler C., Halldin C., Farde L. Synthesis of [123I]-, [125I]- and unlabelled (S)-3-iodo-5,6-dimethoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl]salicylamide (NCQ 298). selective ligands for the study of dopamine D-2 receptors. Acta Pharm. Nord. 1990; 2: 53–60
- Köhler C., Ericsson H., Högberg T., Halldin C., Chan-Palay V. Dopamine D2 receptors in the rat, monkey and post-mortem human hippocampus. An autoradiographic study using the novel D2-selective ligand 125I-NCQ 298. Neurosci. Left. 1991; 125: 12–14
- Köhler C., Ericsson H., Radesäter A. C. Different laminar distributions of dopamine D1 and D2 receptors in the rat hippocampal region. Neurosci. Lett. 1991; 126: 107–109
- Malmberg Å., Jackson D. M., Eriksson A-M., Mohell N. Unique binding characteristics of antipsychotic agents nteracting with human dopamine D2A, D2B and D3 receptors. Mol. Pharmacol. 1993; 43: 749–754
- Markwell M. A.K., Haas S. M., Bieber L. L., Tolbert N. E. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 1978; 87: 206–210
- Munson P. J., Rodbard D. LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 1980; 107: 220–239
- Weiland G. A., Molinoff P. B. Quantitative analysis of drug-receptor interactions: I. Determination of kinetic and equilibrium properties. Life Sci. 1981; 29: 313–330
- Dewar K. M., Montreuil B., Grondin L., Reader T. A. Dopamine D2 receptors labeled with [3H]raclopride in rat and rabbit brains. Equilibrium binding. kinetics, distribution and selectivity. J. Pharmacol. Exp. Ther. 1989; 250: 696–706
- Neve K. A., Henningsen R. A., Kinzie J. M., De Paulis T., Schmidt D. E., Kessler R. M., Janowsky A. Sodium-dependent isomerization of dopamine D-2 receptors characterized using [125I]epidepride. a high-affinity substituted benzamide ligand. J. Pharmacol. Exp. Ther. 1990; 252: 1108–1116
- Niznik H. B., Grigoriadis D. E., Pri-Bar I., Buchman O., Seeman P. Dopamine D2 receptors selectively labeled by a benzamide neuroleptic: [3H]-YM-09151-2. Naunyn-Schmiedeberg's Arch. Pharmacol. 1985; 329: 333–343
- Hulme E. C., Birdsall N. J.M. Receptor-Ligand Interactions: A Practical Approach, E. C. Hulme. Oxford University Press, New York 1992